Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses

Anastasiou, 2012, Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis, Nat. Chem. Biol., 8, 839, 10.1038/nchembio.1060 Baitsch, 2012, The three main stumbling blocks for anticancer T cells, Trends Immunol., 33, 364, 10.1016/j.it.2012.02.006 Blagih, 2015, The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo, Immunity, 42, 41, 10.1016/j.immuni.2014.12.030 Borge, 2003, Insulin receptor substrate 1 regulation of sarco-endoplasmic reticulum calcium ATPase 3 in insulin-secreting beta-cells, J. Biol. Chem., 278, 11359, 10.1074/jbc.M209521200 Braumüller, 2013, T-helper-1-cell cytokines drive cancer into senescence, Nature, 494, 361, 10.1038/nature11824 Callahan, 2010, Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy, Semin. Oncol., 37, 473, 10.1053/j.seminoncol.2010.09.001 Cerami, 2012, The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov., 2, 401, 10.1158/2159-8290.CD-12-0095 Cham, 2008, Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells, Eur. J. Immunol., 38, 2438, 10.1002/eji.200838289 Chang, 2013, Posttranscriptional control of T cell effector function by aerobic glycolysis, Cell, 153, 1239, 10.1016/j.cell.2013.05.016 Dankort, 2009, Braf(V600E) cooperates with Pten loss to induce metastatic melanoma, Nat. Genet., 41, 544, 10.1038/ng.356 Doedens, 2013, Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen, Nat. Immunol., 14, 1173, 10.1038/ni.2714 Feske, 2012, Ion channels and transporters in lymphocyte function and immunity, Nat. Rev. Immunol., 12, 532, 10.1038/nri3233 Finlay, 2012, PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells, J. Exp. Med., 209, 2441, 10.1084/jem.20112607 Frauwirth, 2002, The CD28 signaling pathway regulates glucose metabolism, Immunity, 16, 769, 10.1016/S1074-7613(02)00323-0 Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci. Signal., 6, 10.1126/scisignal.2004088 Gubser, 2013, Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch, Nat. Immunol., 14, 1064, 10.1038/ni.2687 Gullino, 1964, The Interstitial Fluid of Solid Tumors, Cancer Res., 24, 780 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Ho, 2011, Cytoplasmic receptor-interacting protein 140 (RIP140) interacts with perilipin to regulate lipolysis, Cell. Signal., 23, 1396, 10.1016/j.cellsig.2011.03.023 Ho, 2014, Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNγ, Cancer Res., 74, 3205, 10.1158/0008-5472.CAN-13-3461 Macintyre, 2014, The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function, Cell Metab., 20, 61, 10.1016/j.cmet.2014.05.004 MacIver, 2013, Metabolic regulation of T lymphocytes, Annu. Rev. Immunol., 31, 259, 10.1146/annurev-immunol-032712-095956 Maude, 2014, Chimeric antigen receptor T cells for sustained remissions in leukemia, N. Engl. J. Med., 371, 1507, 10.1056/NEJMoa1407222 Mellman, 2011, Cancer immunotherapy comes of age, Nature, 480, 480, 10.1038/nature10673 Michalek, 2011, Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets, J. Immunol., 186, 3299, 10.4049/jimmunol.1003613 Moran, 2011, T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse, J. Exp. Med., 208, 1279, 10.1084/jem.20110308 Parry, 2005, CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms, Mol. Cell. Biol., 25, 9543, 10.1128/MCB.25.21.9543-9553.2005 Pearce, 2013, Fueling immunity: insights into metabolism and lymphocyte function, Science, 342, 1242454, 10.1126/science.1242454 Qin, 2013, Hydrogen peroxide-mediated SERCA cysteine 674 oxidation contributes to impaired cardiac myocyte relaxation in senescent mouse heart, J. Am. Heart Assoc., 2, e000184, 10.1161/JAHA.113.000184 Safford, 2005, Egr-2 and Egr-3 are negative regulators of T cell activation, Nat. Immunol., 6, 472, 10.1038/ni1193 Schwartz, 2003, T cell anergy, Annu. Rev. Immunol., 21, 305, 10.1146/annurev.immunol.21.120601.141110 Sharov, 2006, Quantitative mapping of oxidation-sensitive cysteine residues in SERCA in vivo and in vitro by HPLC-electrospray-tandem MS: selective protein oxidation during biological aging, Biochem. J., 394, 605, 10.1042/BJ20051214 Shiao, 2011, Immune microenvironments in solid tumors: new targets for therapy, Genes Dev., 25, 2559, 10.1101/gad.169029.111 Smith-Garvin, 2009, T cell activation, Annu. Rev. Immunol., 27, 591, 10.1146/annurev.immunol.021908.132706 Srinivasan, 2007, Reciprocal NFAT1 and NFAT2 nuclear localization in CD8+ anergic T cells is regulated by suboptimal calcium signaling, J. Immunol., 179, 3734, 10.4049/jimmunol.179.6.3734 Staron, 2014, The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection, Immunity, 41, 802, 10.1016/j.immuni.2014.10.013 Vander Heiden, 2010, Evidence for an alternative glycolytic pathway in rapidly proliferating cells, Science, 329, 1492, 10.1126/science.1188015 Wang, 2011, The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation, Immunity, 35, 871, 10.1016/j.immuni.2011.09.021 Wang, 2011, Early T cell signalling is reversibly altered in PD-1+ T lymphocytes infiltrating human tumors, PLoS ONE, 6, e17621, 10.1371/journal.pone.0017621 Ward, 2012, Metabolic reprogramming: a cancer hallmark even warburg did not anticipate, Cancer Cell, 21, 297, 10.1016/j.ccr.2012.02.014 Wherry, 2011, T cell exhaustion, Nat. Immunol., 12, 492, 10.1038/ni.2035 Wolchok, 2013, Nivolumab plus ipilimumab in advanced melanoma, N. Engl. J. Med., 369, 122, 10.1056/NEJMoa1302369 Yang, 2013, Oncometabolites: linking altered metabolism with cancer, J. Clin. Invest., 123, 3652, 10.1172/JCI67228 Ying, 2012, Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism, Cell, 149, 656, 10.1016/j.cell.2012.01.058 Zheng, 2009, Anergic T cells are metabolically anergic, J. Immunol., 183, 6095, 10.4049/jimmunol.0803510